181 related articles for article (PubMed ID: 37511100)
1. Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction.
Abo-Aly M; Shokri E; Chelvarajan L; Tarhuni WM; Tripathi H; Abdel-Latif A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511100
[TBL] [Abstract][Full Text] [Related]
2. The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events.
Zhou X; Liu XL; Ji WJ; Liu JX; Guo ZZ; Ren D; Ma YQ; Zeng S; Xu ZW; Li HX; Wang PP; Zhang Z; Li YM; Benefield BC; Zawada AM; Thorp EB; Lee DC; Heine GH
Medicine (Baltimore); 2016 May; 95(18):e3466. PubMed ID: 27149446
[TBL] [Abstract][Full Text] [Related]
3. Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.
Dong S; Ji W; Zeng S; Miao J; Yan L; Liu X; Liu J; Zhou X; Yang Q
J Cardiovasc Transl Res; 2020 Dec; 13(6):916-927. PubMed ID: 32557321
[TBL] [Abstract][Full Text] [Related]
4. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction.
Tapp LD; Shantsila E; Wrigley BJ; Pamukcu B; Lip GY
J Thromb Haemost; 2012 Jul; 10(7):1231-41. PubMed ID: 22212813
[TBL] [Abstract][Full Text] [Related]
5. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
Arslan U; Kocaoğlu I; Balci MM; Gülkan B; Falay MY; Temizhan A
Coron Artery Dis; 2013 Aug; 24(5):404-11. PubMed ID: 23612365
[TBL] [Abstract][Full Text] [Related]
6. LPS differentially affects expression of CD14 and CCR2 in monocyte subsets of Post-STEMI patients with hyperglycemia.
Blanks AM; Pedersen LN; Caslin HL; Mihalick VL; Via J; Canada JM; Van Tassell B; Carbone S; Abbate A; Lee Franco R
Diabetes Res Clin Pract; 2022 Sep; 191():110077. PubMed ID: 36089102
[TBL] [Abstract][Full Text] [Related]
7. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
8. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
[TBL] [Abstract][Full Text] [Related]
9. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
[TBL] [Abstract][Full Text] [Related]
10. Effect of Interleukin-17 in the Activation of Monocyte Subsets in Patients with ST-Segment Elevation Myocardial Infarction.
Garza-Reyes MG; Mora-Ruíz MD; Chávez-Sánchez L; Madrid-Miller A; Cabrera-Quintero AJ; Maravillas-Montero JL; Zentella-Dehesa A; Moreno-Ruíz L; Pastor-Salgado S; Ramírez-Arias E; Pérez-Velázquez N; Chávez-Rueda AK; Blanco-Favela F; Vazquez-Gonzalez WG; Contreras-Rodríguez A
J Immunol Res; 2020; 2020():5692829. PubMed ID: 32676508
[TBL] [Abstract][Full Text] [Related]
11. Association between circulating monocyte subsets and in-stent restenosis after coronary stent implantation in patients with ST-elevation myocardial infarction.
Liu Y; Imanishi T; Ikejima H; Tsujioka H; Ozaki Y; Kuroi A; Okochi K; Ishibashi K; Tanimoto T; Ino Y; Kitabata H; Akasaka T
Circ J; 2010 Nov; 74(12):2585-91. PubMed ID: 20944435
[TBL] [Abstract][Full Text] [Related]
12. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
13. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.
Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S
Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477
[TBL] [Abstract][Full Text] [Related]
14. Trajectories of Circulating Monocyte Subsets After ST-Elevation Myocardial Infarction During Hospitalization: Latent Class Growth Modeling for High-Risk Patient Identification.
Zeng S; Yan LF; Luo YW; Liu XL; Liu JX; Guo ZZ; Xu ZW; Li YM; Ji WJ; Zhou X
J Cardiovasc Transl Res; 2018 Feb; 11(1):22-32. PubMed ID: 29313268
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the CD14++CD16+ monocyte population in human bone marrow.
Mandl M; Schmitz S; Weber C; Hristov M
PLoS One; 2014; 9(11):e112140. PubMed ID: 25369328
[TBL] [Abstract][Full Text] [Related]
16. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
Xiang Y; Liang B; Zhang X; Zheng F
Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
[No Abstract] [Full Text] [Related]
17. Post-reperfusion enhancement of CD14(+)CD16(-) monocytes and microvascular obstruction in ST-segment elevation acute myocardial infarction.
Tsujioka H; Imanishi T; Ikejima H; Tanimoto T; Kuroi A; Kashiwagi M; Okochi K; Ishibashi K; Komukai K; Ino Y; Kitabata H; Akasaka T
Circ J; 2010 Jun; 74(6):1175-82. PubMed ID: 20453385
[TBL] [Abstract][Full Text] [Related]
18. Circulating intermediate monocytes CD14++CD16+ are increased after elective percutaneous coronary intervention.
Merinopoulos I; Bhalraam U; Holmes T; Tsampasian V; Corballis N; Gunawardena T; Sawh C; Maart C; Wistow T; Ryding A; Eccleshall SC; Smith J; Vassiliou VS
PLoS One; 2023; 18(12):e0294746. PubMed ID: 38096193
[TBL] [Abstract][Full Text] [Related]
19. CD14
Urbanski K; Ludew D; Filip G; Filip M; Sagan A; Szczepaniak P; Grudzien G; Sadowski J; Jasiewicz-Honkisz B; Sliwa T; Kapelak B; McGinnigle E; Mikolajczyk T; Guzik TJ
Thromb Haemost; 2017 May; 117(5):971-980. PubMed ID: 28229168
[TBL] [Abstract][Full Text] [Related]
20. Circulating CD14
Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
